baber/WOPTO huggingface dataset:
Patent AU-707417-B2 (AU)
Title: Electrical distribution system
Inventor: SHANN PETER CHRISTIAN
IPC: H02J13/00
Filed: 1995-11-14
Granted: 1999-07-08
Abstract: The invention relates to an electrical distribution system for energizing a plurality of electric circuits in accordance with a predetermined delay pattern. The system as described comprises a control unit, a plurality of circuit delay arrangements each associated with an electrical circuit individual thereto and each circuit delay arrangement is identifiable by a circuit code individual thereto and includes a pulse counting arrangement. The control unit is arranged to transmit the circuit codes to the circuit delay arrangements and the pulse count individual to each circuit code, and each circuit delay arrangement identified by its circuit code is arranged to store the pulse count individual to that code. On receipt of a start signal from the control unit, transmitted simultaneously to all the circuit delay arrangements, each circuit delay arrangement starts its respective pulse counting arrangement and energizes its respective electrical circuit when the pulse count is completed.
Patent AU-727049-B2 (AU)
Title: Sustained release formulation
Inventor: KOSEKI NORIMASA
IPC: A61K9/20
Filed: 1997-10-06
Granted: 2000-11-30
Abstract: The present invention relates to a sustained release formulation used for treatment or prevention of diseases, which contains a therapeutically effective substance as an active ingredient, collagen as a drug carrier, and glycosaminoglycan as an additive. The formulation allows controlled release of the therapeutically effective substance.
Patent AU-755486-B2 (AU)
Title: Hemostatic sandwich bandage
Inventor: MACPHEE MARTIN J
IPC: A61L15/44
Filed: 1999-05-19
Granted: 2002-12-12
Abstract: The present invention relates to a haemostatic multilayer bandage that comprises preferably a thrombin layer between two fibrinogen layers. The dressing may contain other resorbable materials such as glycolic acid or lactic acid based polymers or copolymers. The inventive haemostatic sandwich bandage is useful for the treatment of wounded tissue.
Patent AU-627526-B2 (AU)
Title: Radiotelephone with repertory dialler
Inventor: RASMUSSEN POUL ERIK SOGAARD
IPC: H04M1/2757
Filed: 1989-11-24
Granted: 1992-08-27
Abstract: A radio (2) having: a first memory (34) for storing first information items; memory receiving means (18) for temporarily receiving a second memory (20, 36) for storing second items of information; memory access means (30, 44) for accessing both said first and second memories; and user selective transfer means (42, 30, 44) for causing an information item from one said memories to be transferred to the other of said memories. In a preferred form the radio is a radiotelephone, the first and second items of information are telephone numbers and the second memory is a magnetic card or a smart card.
Patent AU-783431-B2 (AU)
Title: Pharmaceutical compositions for buccal and pulmonary application
Inventor: MODI PANKAJ
IPC: A61K31/7105
Filed: 2001-02-21
Granted: 2005-10-27
Abstract: Pharmaceutical compositions comprising a macromolecular pharmaceutical agent in mixed micellar form are disclosed. The mixed micelles are formed from an alkali metal alkyl sulfate, and at least three different micelle-forming compounds as described in the specification. Micelle size ranges between about 1 and 10 nanometers. Methods for making and using the compositions are also disclosed. A preferred method for administering the present composition is through the buccal region of the mouth.
Patent AU-626968-B2 (AU)
Title: Method for information communication between concurrently operating computer programs
Inventor: GOOD WILLIAM E
IPC: G06F17/24
Filed: 1990-01-16
Granted: 1992-08-13
Abstract: A method of communication in a computer system is provided for transferring information between multiple, concurrently operating programs, each of which may have a respective window display. The user communicates with each of the application programs through the window display as well as through an input device, such as a mouse or keyboard. A list of information codes is registered with a dispatcher program for each of the application programs which requires data. One or more of the application programs generate templates which include data and a corresponding information code. The generated templates are transmitted to the dispatcher program. The dispatcher program then compares the information code in the received template to the registered list of information codes to find any matches and thereby identify the one or more application programs which have registered to receive the information in the received template. The dispatcher program then transmits the received template to each of the identified application programs. Information communication is therefore carried out between multiple operating programs without user direction for the steps of the communication process.
Patent AU-618458-B2 (AU)
Title: Single-phase or polyphase medium-voltage switching device and a medium-voltage distribution installation assembled therewith
Inventor: TAN TJOAN SIOE RUTGER
IPC: H02B13/035
Filed: 1990-03-21
Granted: 1991-12-19
Abstract: Single-phase or polyphase medium-voltage switching device, comprising a metal housing constructed from a generally rectangular metal container (2) having side walls (3, 4, 5, 6), a bottom wall (7) and uprights (15) fitted near the corner points of the bottom wall (7). For accomodating the actuating mechanism of one or more switches provided in the space bounded by the uprights (15), the metal container has a mechanically rigid construction. The one or more switches and further components are combined by a solid insulation, such as casting resin, to form a single structural entity and being suspended from the bottom plate (7) of the container (2). For closing the housing metal plates (16) have to be attached to the uprights. The container has to be closed by means of a metal top plate (17). A medium-voltage distribution installation can be built up from two or more switching devices, adjacently arranged, wherein the containers (2) and uprights (15) situated next to each other being mutually coupled and provided at least in pairs with a common top plate (17).
Patent AU-763076-B2 (AU)
Title: Apparatus for displaying images to viewers in motion
Inventor: SPODEK JOSHUA D
IPC: G09F19/14
Filed: 1999-07-28
Granted: 2003-07-10
Abstract: Apparatus for displaying still images to viewers in motion relative to those images, such as passengers on a subway train, includes a plurality of images mounted on a surface, and a slitboard mounted between that surface and the viewer. As the viewers pass by, the slitboard acts like a shutter, creating an animation effect. In addition, there is a stretching or widening effect that enlarges the images, allowing images to be "preshrunk," thereby allowing a large number of images in a small space, increasing the available frame rate of the animation. The stretching effect depends on the distance between the image surface and the slitboard.
Patent AU-678415-B2 (AU)
Title: Therapeutic anti-HIV oligonucleotide and pharmaceutical
Inventor: AGRAWAL SUDHIR
IPC: C12N15/09
Filed: 1993-10-04
Granted: 1997-05-29
Abstract: Disclosed are oligonucleotides having nucleotide sequences that hybridize to at least nucleotides 324 to 348 of a conserved gag region of the HIV-1 genome. These oligonucleotides have about 25 to 30 nucleotides linked by at least one non-phosphodiester internucleotide linkage which render them resistant to nuclease digestion. Also disclosed are therapeutic formulations containing such oligonucleotides and methods of inhibition HIV-1 proliferation and of treating HIV-1 infection in a mammal.
Patent AU-709197-B2 (AU)
Title: Peptide compositions with growth factor-like activity
Inventor: BHATNAGAR RAJENDRA S
IPC: A61K47/30
Filed: 1996-04-18
Granted: 1999-08-26
Abstract: A peptide has been synthesized with the sequence ANVAENA (SEQ ID NO:1). This peptide, designated "cytomodulin," is able to mimic a broad range of activities of TGF- beta 1 in various cell types. Compositions for applications such as tissue repair are provided that comprise a biocompatible matrix having cytomodulin admixed with or carried by the matrix.
Patent AU-629360-B2 (AU)
Title: Screening machine
Inventor: BRUEDERLEIN JOHANNES
IPC: B07B1/30
Filed: 1990-06-19
Granted: 1992-10-01
Abstract: In a screening machine comprising two screening frames (13 and 31) each having mutual oppositely located feed and discharge ends on which there is arranged an elastic screening lining (54) and which are caused to oscillate by independent oscillating drives wherein the two screening frames (13 and 31) are associated with each other at different heights in such a way that the lower region of the upper screening frame (31) and the upper region of the lower screening frame (13) lie in a common plane, that the elastic screening lining (54) is secured to the two screening frame (13, 31) in the common plane thereof and that the upper screening frame (31) is independently driven in a circular configuration at the feed end and the lower screening frame (13) is indepndently driven in a circular configuration at the discharge end.
Patent AU-707047-B2 (AU)
Title: Contraceptive transcervical fallopian tube occlusion devices and their delivery
Inventor: NIKOLCHEV JULIAN
IPC: A61F6/18
Filed: 1996-05-21
Granted: 1999-07-01
Abstract: The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or a copper alloy. The device is anchored within the fallopian tube by imposing a secondary shape on a resilient structure, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. The resilient structure is then restrained by the walls of the fallopian tube, imposing anchoring forces as it tries to resume the secondary shape.
Patent AU-659575-B2 (AU)
Title: Retroviral protease inhibiting compounds
Inventor: KEMPF DALE J
IPC: A61K45/06
Filed: 1993-12-16
Granted: 1995-05-18
Abstract: A retroviral protease inhibiting compound of formula (A) is disclosed for use in combination with other active pharmaceutical agents for treating a human infected by HIV. Intermediates and processes useful in the manufacture of compounds of formula (A) are also disclosed. <CHEM>
Patent AU-599326-B2 (AU)
Title: Amino acid derivatives
Inventor: GRONVALD FREDERIK CHRISTIAN
IPC: A61K31/443
Filed: 1986-06-26
Granted: 1990-07-19
Abstract: 1-Aminobut-3-en derivatives having optionally substituted furanyl, thienyl, pyridyl and/or pyrrolyl in the 4-position and 3-carboxypiperidin-1-yl, 3-carboxytetrahydropyrid-1-yl or 3 carboxymethylpyrrolidin-1-yl in the 1-position potentiate GABA-ergic neurotransmission.
Patent AU-592389-B2 (AU)
Title: Antigenic proteins and vaccines containing them for prevention of coccidiosis
Inventor: NEWMAN KAREL Z JR
IPC: C12N1/12
Filed: 1986-12-01
Granted: 1990-01-11
Abstract: Isolated genomic DNA molecule having a defined nucleic acid sequence and encoding an antigenic protein (I) derived from Eimeria tenella is new. (I) has a molecular wt. of about 25000 daltons and is composed of two polypeptides joined by a disulphide bond. One polypeptide has a molecular wt. of about 17000 daltons, has a blocked N-terminal amino acid and a defined amino acid sequence. The other polypeptide has a molecular wt. of about 8000 daltons and a defined amino acid sequence.
Patent AU-539503-B2 (AU)
Title: Method for making methanol
Inventor: MEDNICK R LAWRENCE
IPC: C07C29/15
Filed: 1981-02-09
Granted: 1984-10-04
Abstract: Methanol is made in a liquid-phase methanol reactor by entraining a methanol-forming catalyst in an inert liquid and contacting said entrained catalyst with a synthesis gas comprising hydrogen and carbon monoxide.
Patent AU-734098-B2 (AU)
Title: Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals
Inventor: SUNVOLD GREGORY D
IPC: A23K1/16
Filed: 1998-04-06
Granted: 2001-06-07
Abstract: A process for feeding an animal a diet which alters the function and morphology of the gastrointestinal tract (GIT), a large lymphoid organ in the animal and which improves glucose metabolism, satiety, and nutrient absorption. The process involves feeding a companion animal such as, for example, a dog or cat a diet of a pet food composition containing fermentable fibers which have an organic matter disappearance (OMD) of 15 to 60 percent when fermented by fecal bacteria for a 24 hour period, the fibers being present in amounts from about 1 to 11 weight percent of supplemental total dietary fiber. The animal is maintained on the diet for a sufficient period of time to allow the fermentable fibers to ferment in the GIT of the animal.
Patent AU-765576-B2 (AU)
Title: Obscurant device
Inventor: COLLINS PETER JOHN DAVID
IPC: F42B12/70
Filed: 2000-08-21
Granted: 2003-09-25
Abstract: Many of today's weapons systems use surveillance and target acquisition (STA) devices which can exploit the infrared and millimeter wavebands of the electromagnetic spectrum. Designing obscurant devices which can provide screening against such systems often results in complicated or costly solutions. A device capable of mitigating these problems is described wherein an obscurant device (10), and more particularly a device capable of providing screening against the visual, infrared and millimeter wave regions of the electromagnetic spectrum, comprises an obscurant payload, a burster charge capable, when detonated by a detonator, of disseminating said payload and a payload casing wherein some or all of the payload casing is configured to disintegrate upon actuation of the burster charge and to act thereafter as an obscurant.
Patent AU-543054-B2 (AU)
Title: Heterocyclic amine derivatives
Inventor: VILLANI FRANK
IPC: C07D409/04
Filed: 1981-06-16
Granted: 1985-03-28
Abstract: The invention concerns compounds of the general formulaThe compounds are antihistamines with little or no sedative effects.
Patent AU-543923-B2 (AU)
Title: Rack roller
Inventor: MICHELET JACQUES
IPC: B22D11/128
Filed: 1981-07-01
Granted: 1985-05-09
Abstract: A roll for guiding a cast metal strand emanating from a continuous casting machine comprises a cylindrical envelop rotatable about its axis by contact with the cast metal strand. A pair of tubular spindles project from opposite ends of the envelop coaxially fixed thereto and rotably mounted in the region of the outer ends in ball bearings fixed to the machine frame. A central tubular arbor equiped in a central portion thereof with an inductor extends with radial clearance through the spindles and is supported at end portions thereof projecting beyond the spindles in cradles fixed to the machine frame. A key or the like is provided in one of the cradles engaging in a cutout of the central arbor to prevent rotation of the latter during rotation of the envelop and the spindles connected thereto.
Patent AU-678516-B2 (AU)
Title: Process for making steel and hydraulically active binders
Inventor: EDLINGER ALFRED
IPC: C21C5/28
Filed: 1994-08-24
Granted: 1997-05-29
Abstract: The process for making steel and hydraulically active binders uses slags rich in iron oxide, such as steel slag, as oxidizing agent for carbon in pig iron. The slag is reduced, yielding a type of blast furnace slag with improved hydraulic properties.
Patent AU-634395-B2 (AU)
Title: Fluorogenic peptides and their use in the determination of enzymatic activities
IPC: C07K7/08
Filed: 1991-04-16
Granted: 1993-02-18
Abstract: A fluorogenic peptide exhibiting intramolecular quenching having the general formula F-A-Q-Y1 or Y2-Q-A-F wherein Q is a fluorescence quenching substituted amino acid residue (I) wherein R1, R2, R3, R4 and R5 are independently selected from hydrogen, hydroxy, alkyl, alkoxy, amino, nitro, amido, halogen, aryl or aralkyl, with the proviso that at least one of R1 to R5 is hydroxy and at least one is nitro, wherein X is a spacing group which may be absent or selected from any combination of -CO-NH-, -CO-O-, -S-, -S-S-, -O-, -NH- or -C6H4-, and n and m are integers from 0 to 10, F is a fluorescent group having a maximum emission within the absorption band for the quenching residue Q, A is a spacing entity selected from amino acid residues and peptide residues and may include a non-peptide molecular entity, e.g. a mono- or oligosaccharie being linked to the fluorescent group F via an amide bond or ester bond, Y1 is OH, NH2, an amino acid residue, a peptide residue which is preferably attachable to a solid phase or a C-terminal protective group, Y2 is H, an amino acid residue, a peptide residue or an N-terminal protective group. Preferred peptides are those, wherein Q is 3-nitro-tyrosine, i.e. F1-A1-Tyr(NO2)-Y1 wherein F1 is a fluorescent group having a maximum emission of from 400 to 460 nm, preferably anthraniloyl, A1 is an amino acid residue or a peptide residue, preferably having 2 to 15 amino acids, and linked to the group F via a peptide bond, and Y1 is as defined above. The peptides are useful as substrates for determination of enzymatic activities in a sample, e.g. biological systems by incubating with the sample under conditions favourable to enzymatic activities, and determining and comparing the fluorescence emitted before and after the incubation. The peptides may advantageously be prepared by parallel multi-column solid phase synthesis.
Patent AU-644458-B2 (AU)
Title: Novel piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
Inventor: MCCARTHY JAMES RAY
IPC: C07D211/42
Filed: 1991-07-19
Granted: 1993-12-09
Abstract: The present invention relates to certain novel piperidyl ethers and thioethers and to pharmaceutical compositions containing these which are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in patients in need thereof.
Patent AU-635653-B2 (AU)
Title: Self-sticking matrix system for the sustained transcutaneous release of piribedil
IPC: A61K31/505
Filed: 1991-07-22
Granted: 1993-03-25
Abstract: The invention relates to a self-adhesive silicone elastomer matrix system for the sustained release of piribedil, which provides for the continuous and steady transdermal diffusion of piribedil.
Patent AU-688410-B2 (AU)
Title: Flock separating apparatus
Inventor: SUOMINEN HANNU L
IPC: B03D1/14
Filed: 1994-11-18
Granted: 1998-03-12
Abstract: PCT No. PCT/FI94/00518 Sec. 371 Date May 19, 1997 Sec. 102(e) Date May 19, 1997 PCT Filed Nov. 18, 1994 PCT Pub. No. WO96/15989 PCT Pub. Date May 30, 1996A flock separating apparatus, has an electrolytic cell (2) fitted with iron electrode and a separating tank (3), wherein the flock is carried upwards by a hydrogen gas produced in electrolysis. The separating tank (3) has a substantially vertical pipe having a length which is at least 10 times, preferably at least 15-20 times more than its diameter.
Patent AU-691210-B2 (AU)
Title: Cyclic carbonate-curable coating composition
Inventor: DECEMBER TIMOTHY S
IPC: C09D5/44
Filed: 1994-12-21
Granted: 1998-05-14
Abstract: A coating composition is described comprising, in an aqueous medium:       A) a resin having a plurality of primary amine groups, and B) a curing agent having a plurality of cyclic carbonate groups.
Patent AU-745842-B2 (AU)
Title: Signal processing system
Inventor: DAVIES THOMAS RICHARD
IPC: H03F1/34
Filed: 1998-07-16
Granted: 2002-04-11
Abstract: A signal processing system including at least one control loop having a forward path and a feedback path. A signal processor produces a representation of the desired downstream output amplitude and phase as a pair of substantially orthogonal signal components. A feedback-path splitter splits a feedback signal into a plurality of substantially orthogonal feedback signal components which are combined with the corresponding substantially orthogonal signal components to create error signals. A plurality of modulators control the amplitude, frequency, and/or phase of the pair of substantially orthogonal signal components on the basis of control signals which are derived from the error signals. The outputs of the plurality of modulating means are then combined into an output signal. A phase-shift controller in the forward path of the control loop derives the control signals from the error signals on the basis of monitored signal values from at least one predetermined point in the signal processing system.
Patent AU-635669-B2 (AU)
Title: Peptide with activity of inhibiting phospholipase a2 originating in inflamed part
IPC: A61K38/00
Filed: 1991-10-17
Granted: 1993-03-25
Abstract: A peptide with an activity of inhibiting phospholipase A2 originating in inflamed parts, which has an amino acid sequence represented by formula (I). <IMAGE>
Patent AU-657109-B2 (AU)
Title: Ligand-mediated immunofunctional hormone binding protein assay method
Inventor: CARLSSON LENA MARIANA SUSANN
IPC: C12Q1/28
Filed: 1991-11-19
Granted: 1995-03-02
Abstract: A ligand-mediated immunofunctional assay (LIFA) method for detecting the presence and the concentration of polypeptide hormone binding proteins which comprises capturing the binding protein with a solid phase bound first antibody, saturating the bound hormone binding protein with the ligand polypeptide hormone, and detecting the bound ligand polypeptide hormone with a detectably labeled second antibody specific for the ligand polypeptide hormone. In the absence of added saturating polypeptide hormone, the LIFA measures the amount of hormone binding protein bound to the endogenous ligand polypeptide hormone. A growth hormone binding protein assay illustrates the method of the present invention. LIFA assay results indicate that increased binding protein substantially increases growth hormone activity. Methods of use and formulations of growth hormone binding protein, growth hormone, insulin-like growth factor-I and insulin-like growth factor binding protein are disclosed.
Patent AU-555893-B2 (AU)
Title: (1,2)-heterofused-1,4-benzodiazepine
Inventor: LIEPMANN HANS
IPC: C07D498/04
Filed: 1982-12-24
Granted: 1986-10-16
Abstract: [1,2]-fused 1,4-benzodiazepine compounds are disclosed corresponding to the general formula I    <IMAGE>  I  wherein X is an oxygen or sulfur atom or an optionally substituted imino group, R1 is a hydrogen or halogen atom, lower alkyl radical, a lower alkoxy radical or a nitro group and R2 is a hydrogen or halogen atom, a lower alkyl radical, a lower alkoxy radical or a nitro group, or if R1 is a hydrogen atom, R2 may also be a lower alkylthio radical, or, if R1 is a hydrogen atom and X is a sulfur atom or an imino group, R2 may be a trifluoromethyl radical; or R1 and R2 are bonded to adjacent carbon atoms and together denote a methylenedioxy or ethylenedioxy radical; R3 is an optionally substituted furyl, thienyl, pyrrolyl or pyridyl radical and n is zero or, if R3 is furyl or thienyl, n may be 0 or 1. The compounds may be in the form of their optical isomers or acid addition salts. The compounds exhibit neuroleptic properties. Processes for preparing the compounds and pharmaceutical compositions containing them are also disclosed.